LGE-CMR Border Zone to Predict ICD Therapy arrhythmic outcomes. [9] [10] [11] [12] [13] Furthermore, detailed characterization of the heterogeneous border zone surrounding the core scar on LGE CMR has been linked to all-cause mortality and more frequent ventricular arrhythmias in patients with coronary artery disease [14] [15] [16] [17] and also in NICM patients. 9, [17] [18] [19] [20] Currently, there is no consensus on which algorithm to use to assess LGE border zone. 21 The heterogeneity of LGE areas has been analyzed using methods based on both threshold algorithms 14, 22, 23 and full-width half-maximum (FWHM) algorithms. 15, 16 In 2008, our group presented a semiautomatic algorithm based on a pixel weighting approach for infarct/ fibrosis quantification that accounts for partial volume effects and has the potential to quantify LGE border zone. 24 Recently, we developed and validated a new semiautomatic algorithm for infarct/fibrosis and LGE border zone analysis that also incorporates intensity thresholding by expectation maximization. 25 The semiautomatic methods require less user input and are more automated than current approaches for determining LGE border zone.
Thus, we hypothesized that a heterogeneous LGE border zone is related to appropriate ICD therapy and best predicts outcomes compared with other LGE characteristics. The aims of this study were to (1) determine whether the size and heterogeneity of LGE can predict appropriate ICD therapy, and (2) evaluate 2 new semiautomatic LGE border zone algorithms and determine whether they have similar predictive values as 2 previously reported heterogeneity algorithms.
Materials and Methods

Study Population and Follow-Up
Patients with systolic heart failure undergoing primary or secondary prophylactic treatment with ICD between 2003 and 2013 at Lund University Hospital and who had undergone a CMR examination were retrospectively included. Indications for the CMR exams were primarily infarct/fibrosis and left ventricular volumes assessment. The study was approved by the Regional Ethics Committee and conformed to the Declaration of Helsinki. Informed consent was waived by the Ethics Committee because of the retrospective nature of the study.
All patients had clinical signs of heart failure and left ventricular dysfunction with LVEF <50%. The pathogenesis of cardiac disease was determined in accordance with previously validated criteria. 26 Criteria for ICM were one of the following: (1) history of myocardial infarction in medical record, (2) previous percutaneous coronary intervention or coronary artery bypass surgery, (3) significant angiographic stenosis ≥70% in >1 epicardial artery, or (4) ≥50% in left main or proximal left ascending artery. Patients not fulfilling criteria for ICM were classified as NICM.
The primary patient outcome was appropriate ICD therapy for ventricular tachycardia or ventricular fibrillation (defined as antitachycardia pacing (ATP), shock, or both). Inappropriate ICD therapy included ICD therapy because of lead noise, atrial fibrillation, atrial flutter, or other supraventricular tachycardia and was not registered as an end point. Follow-up was performed every 6 months during the first year after implantation of the device and then by chart review of patient visits and interrogation data from the implanted device. Cardiovascular mortality was also assessed and defined as death because of acute myocardial infarction, heart failure, SCD, or arrhythmic death. As a composite secondary end point, appropriate ICD therapy and cardiovascular mortality was assessed.
CMR Protocol
Imaging was performed on a clinical 1.5T magnetic resonance imaging scanners, a Philips Achieva (Best, the Netherlands), using a 5-or a 32-channel coil. Left ventricular function was assessed by cine imaging in breath hold both in short-axis and long-axis projections. LGE CMR images were acquired with either a 2D (n=13) or a 3D inversion recovery gradient echo (n=95) mid-diastole during end expiratory breath hold. See Data Supplement for CMR parameter details. Short-axis slices covering the entire left ventricle from base to apex and 3 long-axis projections were collected 10 to 20 minutes after administration of 0.2 mmol/kg of gadolinium-based contrast agent (gado-pentetate dimeglumine or gadoteric acid). The inversion time was adjusted to null remote myocardium.
Image Analysis
All image analysis was performed using the software Segment v2.0 (http://segment.heiberg.se). 27 Images were assessed regarding image quality and classified as diagnostic or nondiagnostic by 2 observers (Drs Jablonowski and Engblom; see Figure I in the Data Supplement for details). Patients with nondiagnostic images were excluded from further analysis.
Global Left Ventricular Parameters
LVEF, end-diastolic volume, and end-systolic volume were determined by manually delineating the endocardium in short-axis cine images at both end systole and end diastole.
LGE Border Zone Algorithms
Hyperenhancement on LGE CMR was quantified on short-axis images by first delineating the endocardium and epicardium and then using 4 different algorithms ( Figure 1 ) to quantify the total LGE, core LGE, and the LGE border zone:
1. A newly developed semiautomatic quantitative weighted border zone algorithm (WBZ) based on expectation maximization for intensity classification resulting in a volume with hyperenhancement (total LGE), weighted summation of infarct size to account for partial volume effects inside the hyperenhanced volume according to pixel intensity, and a priori information used for pre-and postprocessing (EWA). 25 2. A previously developed semiautomatic quantitative WBZ. 24 The algorithm automatically detected a remote region of interest (ROI) and an optimized 1.8 SD above mean signal intensity in the remote region to define the area containing hyperenhancement (total LGE) followed by weighting similar to the EWA method above. For both, EWA and WBZ, LGE border zone was quantified as the difference in total and core LGE (weighted infarct volume).
3. A modified FWHM (mFWHM) algorithm. 15 A ROI was drawn around the LGE and in remote myocardium. Core LGE was defined as signal intensity (SI)>50% of maximal SI in LGE ROI.
LGE border zone was defined as SI>maximal SI from remote ROI but SI<50% of maximal SI of the core LGE. 4. A 2-3SD threshold algorithm (2-3SD).
14 ROIs were drawn analogously to the mFWHM method. LGE border zone was defined as myocardium with SI between 2 SD and 3 SD from remote myocardium.
LGE border zone was normalized to total LGE and expressed in percent. See Data Supplement for details on algorithms.
Statistical Analysis
Results are expressed as mean±SD if not stated otherwise. Differences in baseline characteristics among patients with and without appropriate ICD therapy were assessed by the independent samples t test, Fisher exact test, or Mann-Whitney U test as appropriate. Univariable and multivariable Cox regression analyses were used to assess the relation between total LGE, core LGE, and LGE border zone and the primary and secondary end points. Analyses were performed in ICM and NICM patients separately and in ICM subgroups of primary versus secondary preventive ICD. Variables predictive in univariable analysis for each algorithm were included in a multivariable analysis and also adjusted for known predictors of outcome (LVEF). LVEF was included as a continuous variable because LVEF was used to stratify patients at inclusion. Because total LGE is derived partly from LGE border zone and the variables are strongly related in ICM patients (Pearson correlation 0.8; P<0.001), only core LGE was included in multivariable analysis. In NICM patients, the number of events was small, and therefore, no multivariable analysis was performed. See Data Supplement for further details.
Hazard ratios (HRs) were expressed as risk increase (or decrease) per 1% increase in total, core, or border zone LGE volume.
Event-free time was assessed by Kaplan-Meier curves using the log-rank test stratified by median LGE border zone. Differences over time were assessed by the log-rank test. Patients who did not experience an event or inappropriate ICD therapy during follow-up were considered as censored. Interobserver and intraobserver analysis was assessed using bias according to Bland-Altman.
The negative predictive value of a small extent of LGE border zone (less than median LGE border zone) was calculated. Differences with a P<0.05 were considered statistically significant.
Results
Study Population Characteristics and Follow-Up
In the final analysis, 74 patients with ICM and 34 patients with NICM were included after 3 ICM patients and 1 NICM patient were excluded because of nondiagnostic image quality. Baseline patient characteristics are listed in Table 1 . In the ICM cohort, 27 patients experienced appropriate ICD therapy in response to ventricular arrhythmia (ATP alone, n=17 and ATP followed by shock or shock alone, n=10), and in the NICM cohort, 7 patients experienced appropriate ICD therapy (ATP alone, n=4 and ATP followed by shock or shock alone, n=3).
A total of 16 cardiovascular deaths occurred during followup, all in patients with ICM (8 heart failure, 6 SCD, 1 arrhythmic death, and 1 acute myocardial infarction). The median followup time was 63 months (1-140 months) in ICM patients and 52 months (0-133 months) for NICM patients. The median time between CMR examination and ICD implantation was 1 month (0-86) for ICM patients and 1 month (0-53) for NICM patients. The difference in follow-up time between patients with and without appropriate ICD therapy in ICM and NICM patients, as well as in ICM subgroups, was similar (P=0.32-0.70).
CMR Characteristics
CMR characteristics are listed in Tables 1 and 2 . There was no statistical difference in LVEF among ICM patients with and without ICD therapy (29±11 versus 26±10; P=0.32) or among NICM patients (30±14 versus 28±11; P=0.66).
In patients with ICM, there was no statistical difference in total LGE, core LGE, or LGE border zone between groups with and without ICD therapy using the EWA, WBZ, and mFWHM algorithms. However, using the 2-3SD algorithm, total and core LGE were significantly larger in ICM patients with appropriate ICD therapy (P<0.05).
In patients with NICM, no statistical difference was seen in LGE border zone between patients with and without ICD therapy, except using the 2-3SD algorithm where LGE border zone was smaller in patients with ICD therapy. Total LGE was larger in NICM patients with ICD therapy using the EWA, WBZ, and 2-3SD algorithm, as well as core LGE using the EWA and 2-3SD algorithm.
Predictors of ICD Therapy
Ischemic Cardiomyopathy
In univariable analyses demonstrated in Figure 2 and Table 3, LGE border zone did not predict ICD therapy in ICM patients using any of the 4 algorithms (EWA: HR, Total LGE demonstrated a shorter time to ICD therapy using the EWA (HR, 1.01; P=0.046), WBZ (HR, 1.01; P=0.02), and 2-3SD algorithms (HR, 1.01; P=0.046), as well as core LGE using the WBZ algorithm (HR, 1.02; P=0.03). In multivariable analysis, adjusting for LVEF, only core LGE using the WBZ algorithm remained a predictor of ICD therapy (Table 4) .
ICM Patients With Primary Versus Secondary Preventive ICD
In patients with primary prevention ICDs, a large compared with small LGE border zone was associated with shorter time to ICD therapy using the EWA algorithm in univariable analyses (Figure 2 ; HR, 1.23; P=0.04), WBZ algorithm (HR, 1.22; P=0.04), and mFWHM algorithm (HR, 1.05; P=0.04) but not using the 2-3SD algorithm (HR, 1.01; P=0.75). In multivariable analysis, adjusting for LVEF, LGE border zone remained a predictor of ICD therapy using the EWA, WBZ, and mFWHM algorithm (Table 4 ). Comparison of late gadolinium enhancement (LGE) border zone algorithms. Representative short-axis LGE cardiac magnetic resonance imaging (CMR) images from 1 patient with ischemic cardiomyopathy (ICM; top row) and from 1 patient with nonischemic cardiomyopathy (NICM; bottom row), evaluated for LGE border zone with 4 different algorithms: (1) expectation maximization, weighted intensity, and a priori information (EWA); (2) weighted border zone (WBZ) algorithm; (3) a modified full-width half-maximum (mFWHM) algorithm; and (4) 2-3SD threshold (2-3SD) algorithm. LGE border zone is defined as the yellow area outside the red area (core LGE). Red line indicates endocardium; and green line, epicardium. Figure 3 shows that the time to ICD therapy in the group with large LGE border zone was shorter compared with patients with small LGE border zone using the EWA (P=0.02), WBZ (P=0.046), and mFWHM algorithm (P=0.03). Using the 2-3SD algorithm, there was no statistical difference in ICD therapy between patients with small and large LGE border zone (P=0.96). LGE border zone, %total LGE  26±4  34±4  41±17  11±7*  24±5  34±5  43±18  20±10 2-3SD indicates 2-3SD threshold algorithm; EWA, expectation maximization, weighted intensity, a priori information algorithm; ICD, implantable cardioverter defibrillator; LGE, late gadolinium enhancement; mFWHM, modified full-width half-maximum algorithm; and WBZ, weighted border zone algorithm. *P<0.05 compared with the same method in patients with no ICD therapy.
Furthermore, the negative predictive value of a small LGE border zone in patients with a primary preventive ICD (n=49) was 92% (95% CI, 76%-98%) for the EWA, WBZ, and mFWHM algorithms.
No other LGE characteristics predicted ICD therapy in patients with primary prevention ICD and in patients with secondary prevention ICD; only total and core LGE using the WBZ algorithm demonstrated slightly shorter time to ICD therapy (HR, 1.02-1.03; P=0.04) in univariable analysis.
Nonischemic Cardiomyopathy
In NICM patients, only total LGE showed a significant shorter time to ICD therapy on univariable analysis (Figure 2 ) for all algorithms (HR, 1.03-1.04; P<0.05) and for core LGE using the EWA, WBZ, and 2-3SD algorithms (HR, 1.04-1.06; P=0.01).
Predictors of ICD Therapy or Cardiac Mortality
LGE border zone was not a predictor of the composite end point of ICD therapy or cardiovascular mortality in any group by any algorithm. In ICM patients, total LGE was weak predictor using the EWA, WBZ, and 2-3SD (HR, 1.01-1.02; P<0.05) as was core LGE using the EWA and WBZ algorithm (HR, 1.02; P<0.05). In NICM patients, total LGE by the EWA, WBZ, mFWHM algorithm and core LGE by the EWA and WBZ algorithm were weak but statistically significant predictors (HR, 1.03-1.06; P<0.05). In ICM patients with secondary preventive ICD, total and core LGE were weak predictors of the end point using the WBZ algorithm (HR, 1.02-1.03; P<0.05). See Figure II and Table II in the Data Supplement for details.
Discussion
The main findings of this study are as follows:
1. The quantification of LGE CMR border zone is the strongest predictor of appropriate ICD therapy, as a surrogate for SCD, in ICM patients with primary prophylactic ICD at medium to long-term follow-up (5.3 years) compared with other clinical and CMR characteristics. 2. The EWA, WBZ, and mFWHM algorithms for LGE border zone may be used interchangeably with a negative predictive value of 92% for the need of an ICD in ICM patients with primary prophylactic ICD. 3. Total LGE by any method is predictive of ICD therapy, as well as ICD therapy and cardiovascular mortality combined, in NICM. The fact that LGE border zone is prognostic in ICM and total LGE in NICM may be caused by different arrhythmogenic properties of fibrosis in ICM and NICM patients. However, because the applied algorithms are primarily indicators of scar heterogeneity rather than LGE border zone size, these findings could be explained by technical limitations in detecting LGE border zone rather than pathophysiological mechanisms.
Comparison to Earlier Studies
Various methods for LGE border zone quantification have been published in the literature, including the FWHM approach 15, 16 and variations of the standard deviation of signal intensity. 14, 22, 23 However, there are no accepted standards for quantification and a continued need for direct comparisons of methods to reach at a consensus. The FWHM method has been previously associated with arrhythmic substrate, as well as arrhythmic outcomes. 15, 17 A small study of 47 patients also reported the association between LGE border zone by 2-3SD and inducibility for ventricular arrhythmia at time of the electrophysiology study. 28 Furthermore, subsequent studies of the 2-3SD method have assessed its predictive value for all-cause mortality.
14 In a subsequent large study on 363 patients with ICM, a variety of Hazard ratios for predicting appropriate implantable cardioverter defibrillator (ICD) therapy. Hazard ratios (HR) and 95% confidence interval (95% CI) using late gadolinium enhancement (LGE) characteristics for the whole study population and subgroups using 4 different algorithms for the primary outcome (appropriate ICD therapy). The highest HR was seen for LGE border zone using the expectation maximization, weighted intensity, and a priori information (EWA), weighted border zone (WBZ), and a modified full-width half-maximum (mFWHM) algorithms in ischemic cardiomyopathy (ICM) patients with primary prophylactic ICD. In nonischemic cardiomyopathy (NICM) patients, total LGE was the only predictor for ICD therapy using all algorithms. For specific HRs and CIs, see Table I in the Data Supplement. *Denotes that 95% CI is not crossing 1.
thresholds (2-5SD) and the FWHM algorithm were used to quantify LGE border zone but found that 2-3SD yielded the most incremental value and association with all-cause mortality. 23 The 2-3SD method was also used in a study on 301 patients where LGE border zone was associated with patient death incremental to LVEF and total scar size. 22 However, the end point in all of these studies was all-cause mortality rather than the arrhythmic end points assessed in our study. Therefore, it may be that the 2-3SD method is more useful in predicting all-cause mortality than it is in predicting appropriate ICD therapy.
In a small, prior study assessing LGE characteristics in 55 ICM patients with primary preventive ICD using 3 different methods (2 of the 3 used in the current study), LGE border zone was not found to add incremental value to arrhythmia prediction, likely because of the small sample size and short follow-up duration 29 compared with our study with longer follow up. However, the same study reported the area under the curve for LGE border zone to be the highest at 0.81 compared with 0.72 to 0.789 for other LGE characteristics. 29 Our results in patients with NICM support other studies that suggest that total LGE is more predictive of ventricular arrhythmic events. 11, 12, [30] [31] [32] However, other recent studies support the association between LGE heterogeneity and ICD therapy in this population, which warrants further study.
17-20
Confounders for LGE Heterogeneity Assessment
The EWA method uses expectation maximization for detecting the infarcted area (total LGE), and thus, at least this part of the analysis algorithm is minimizing the influence of noise on results. Furthermore, both the EWA and WBZ method for LGE border zone quantification use weighting, to correct for partial volume, within the infarcted volume to separate core from LGE border zone and, thus, will not be affected by noise as long as it is Gaussian. As a result, the effect of noise on EWA and WBZ is less than that in a threshold approach.
This may explain the finding of lower total LGE in ICM patients using the 2-3SD method (Table 2 ) compared with the 3 other algorithms, as well as a smaller LGE border zone.
Furthermore, the EWA algorithm closes small gaps between scars, and these filled gaps are within the infarct extent and, thus, defined as LGE border zone. This may be a potential explanation why EWA showed the highest sensitivity to predict ICD therapy.
The EWA and WBZ algorithms have also been validated in vivo and ex vivo for infarct size and does not require user input to determine SI thresholds in remote myocardium.
24,25
Clinical Significance
There is a need to further risk-stratify patients considered for ICD implantation to optimize patient selection, especially when primary prophylactic treatment is considered. Our study shows that LGE border zone discriminates patients with malignant arrhythmias and appropriate ICD therapy in ICM patients with primary prevention indications for ICD. Many patients undergo a CMR examination when ICD implantation is considered to determine the pathogenesis of heart failure. The identification and characterization of the arrhythmogenic LGE border zone is, therefore, available without further cost in these patients and may aid in the risk stratification of ventricular arrhythmias. The current study does not support LGE border zone as a predictor for the combined outcome of ICD therapy and cardiovascular mortality. However, because arrhythmic deaths are avoided by ICD treatment, it is not expected that LGE characteristics predicting correct ICD therapy would predict this cause of death.
Limitations
This retrospective study comprised a relatively small number of patients and has the potential inherent limitations of a retrospective design, including missing data, and possible bias in the patient inclusion because only patients with a CMR performed prior to ICD implantation were included. A limitation in patients with secondary prevention ICD is survivor bias because only patients with smaller scars may have survived SCD. There is potential for interim events to have occurred between the index magnetic resonance imaging and ICD device implantation. Furthermore, the follow-up time is a possible confounding factor when assessing the predictive value of LGE characteristics for ICD therapy. The mean follow-up time was, however, similar in our study for both ICM and NICM groups, with and without therapy, by any analysis algorithm in patients with small or large LGE border zones. The NICM cohort was not powered sufficiently to definitively conclude that there was no statistical difference in LGE border zone characteristics between the group with and without ICD therapy but suggested that total LGE size may be a strong predictor. The scanning was performed on a 1.5T scanner, and the results may differ at other field strengths. Different LGE sequences were used for LGE imaging (2D-IR, 2D-PSIR, and Figure 3 . Event-free survival in ischemic cardiomyopathy (ICM) patients with primary preventive implantable cardioverter defibrillator (ICD). Kaplan-Meier curves demonstrating the differences in appropriate ICD therapy in ischemic cardiomyopathy patients with primary preventive ICD. Patients with larger late gadolinium enhancement (LGE) border zone had significantly shorter time to ICD therapy compared with patients with small LGE border zone, using the expectation maximization, weighted intensity, and a priori information (EWA; P=0.02), weighted border zone (WBZ) algorithm (P=0.046), and modified full-width half-maximum (mFWHM) algorithm (P=0.03). The 2-3SD algorithm did not show a statistical difference between the groups (P=0.96).
3D-IR) and may be a limitation because of possible different image resolution and quality. However, the different LGE sequences have shown good agreement in patients with ICM. 33 The algorithms used could also have performed even better in higher-resolution data sets. 34 Furthermore, LGE quantification approaches in this study are all designed for typical ischemic scars, whereas patients with high incidence of arrhythmias might have different infarcts/fibrosis. For instance, the EWA algorithm assumes that the infarct/fibrotic tissue have a Gaussian signal distribution, and the infarct signal intensity distribution might be skewed in infarcts with larger LGE border zone, leading to a slight underestimation of the LGE border zone.
Conclusion
Appropriate ICD therapy can be predicted in ICM patients with primary prevention ICD by quantifying the LGE border zone. In NICM patients, total LGE but not LGE border zone had a predictive value of appropriate ICD therapy. However, the algorithm used affects the predictive value of these measures. The negative predictive value of LGE border zone in patients with primary prevention ICD suggests that future prospective studies could study whether ICD can be deferred based on CMR characteristics.
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